Skip to main content
TipRanks
Go Ultimate75% OFF

Keymed Biosciences, Inc. (2162) Ownership - Who Owns Keymed Biosciences, Inc.?

1 Followers

Keymed Biosciences, Inc. (2162) Ownership Overview

  • 2.46% Mutual Funds
  • 4.18% ETFs
  • 93.36% Public Companies and Individual Investors

The ownership structure of Keymed Biosciences, Inc. (HK:2162) stock is a mix of institutional, retail, and individual investors. Approximately 6.64% of the company’s stock is owned by Institutional Investors, and 93.36% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

HK:2162 top shareholders
Holder# of SharesType% HoldingValue
Vanguard7,116,569Institution2.38%63,700,409
Ishares4,589,500Institution1.54%41,080,615
Vanguard International Equity Index Funds4,034,500Institution1.35%36,112,810
Vanguard Star Funds3,073,791Institution1.03%27,513,503
Ubs274,500Institution0.09%2,457,050
State Street273,000Institution0.09%2,443,623
Wisdomtree122,000Institution0.04%1,092,022
Fidelity Salem Street Trust121,184Institution0.04%1,084,718
Spdr82,500Institution0.03%738,458
State Street Institutional Investment Trust72,500Institution0.02%648,948

Top Mutual Fund Holders

HK:2162 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard International Equity Index Funds4,034,500Institution1.35%36,112,810
Vanguard Star Funds3,073,791Institution1.03%27,513,503
Fidelity Salem Street Trust121,184Institution0.04%1,084,718
State Street Institutional Investment Trust72,500Institution0.02%648,948
Aim Investment Funds (invesco Investment Funds)37,000Institution0.01%331,187
Wilmington Funds8,630Institution<0.01%77,247
Franklin Alternative Strategies Funds1Institution0.00%9

Top ETF Holders

HK:2162 top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total International Stock ETF, VXUS ETF3,098,791Institution1.04%31,994,277
Vanguard FTSE Emerging Markets ETF, VWO ETF2,984,000Institution1.00%30,809,087
iShares Core MSCI Emerging Markets ETF, IEMG ETF2,436,500Institution0.82%21,753,062
Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF783,000Institution0.26%8,084,288
iShares Core MSCI Total International Stock ETF, IXUS ETF312,500Institution0.10%2,789,999
SPDR Portfolio Emerging Markets ETF, SPEM ETF245,500Institution0.08%2,221,960
Vanguard Total World Stock ETF, VT ETF186,000Institution0.06%1,920,406
iShares MSCI EM IMI ESG Screened UCITS ETF, GB:SEDM ETF122,000Institution0.04%1,108,024
UBS (Lux) Fund Solutions SICAV - Solactive China Technology UCITS ETF, DE:UIC1 ETF91,500Institution0.03%850,031
UBS (Lux) Fund Solutions SICAV - Solactive China Technology UCITS ETF USD, DE:UIC2 ETF91,500Institution0.03%850,031

FAQ

What percentage of Keymed Biosciences, Inc. (HK:2162) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.64% of Keymed Biosciences, Inc. (HK:2162) stock is held by institutional investors: 2.46% by mutual funds and 4.18% by ETFs.
What percentage of Keymed Biosciences, Inc. (HK:2162) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.36% of Keymed Biosciences, Inc. (HK:2162) stock is held by public companies and individual investors.
Who owns the most shares of Keymed Biosciences, Inc. (HK:2162)?
Vanguard owns the most shares of Keymed Biosciences, Inc. (HK:2162).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.